alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 226–250 of 7,816 matching trials · page 10 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Addressing Root Causes for Gun Violence Prevention (ARC-GVP)
NCT05887973
The T.R.I.G.G.E.R Project
Runs in: United States · 1 site 		NA
other		 RECRUITING 250 University of Michigan
OTHER		 2026-08-31
ACP-204 in Adults With Alzheimer's Disease Psychosis
NCT06159673
ACP-204; Placebo
Runs in: Brazil; Bulgaria; Chile; Czechia; France; Italy; Mexico; ... · 149 sites 		PHASE2|PHASE3
other		 RECRUITING 1,074 ACADIA Pharmaceuticals Inc.
INDUSTRY		 2026-08-31
A Portal-based Advance Care Planning Intervention Among Community-Dwelling Persons Living With Cognitive Impairment
NCT06509373
Advance Care Planning Tool - ACPVoice; Standard of Care for Advance...
Runs in: United States · 1 site 		NA
other		 COMPLETED 300 Wake Forest University Health Sciences
OTHER		 2026-08-31
A Study of AMDX-2011P in Participants With Alzheimer's Disease
NCT06514001
AMDX-2011P
Runs in: United States · 1 site 		PHASE2
other		 RECRUITING 25 Amydis Inc.
INDUSTRY		 2026-08-31
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
NCT06540833
ITI-1284; Placebo
Runs in: Bulgaria; Croatia; Czechia; Italy; Poland; Romania; Serbi... · 67 sites 		PHASE2
other		 RECRUITING 370 Intra-Cellular Therapies, Inc.
INDUSTRY		 2026-08-31
A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease
NCT06881836
ONO-2020; Placebo
Runs in: Japan; United States · 80 sites 		PHASE2
other		 ACTIVE_NOT_RECRUITING 260 Ono Pharmaceutical Co., Ltd.
INDUSTRY		 2026-08-31
Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older Adults
NCT06919926
AGB101; Placebo
Runs in: United States · 1 site 		PHASE2
other		 ACTIVE_NOT_RECRUITING 60 Johns Hopkins University
OTHER		 2026-08-31
Genotype, Clinical Features and Imaging of Neuroradiological Abnormalities in CADASIL
NCT06938100
Runs in: Italy; Spain · 2 sites 		NA
other		 RECRUITING 100 Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
OTHER		 2026-08-31
Efficacy and Safety of Transcranial Magnetic Stimulation in Treatment of Alzheimer's Disease
NCT07324161
rTMS; sham rTMS; Accelerated rTMS
Runs in: China · 1 site 		NA
other		 RECRUITING 81 Fujian Medical University Union Hospital
OTHER		 2026-08-31
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
NCT07326709
Votoplam (blinded); Placebo
Runs in: Argentina; Australia; Belgium; Bulgaria; Canada; China; C... · 82 sites 		PHASE3
other		 RECRUITING 770 Novartis Pharmaceuticals
INDUSTRY		 2026-08-31
Home-based Monitoring & Enabled Medication Independence With New Digital Tools
NCT07659548
HOME-MIND 		NA
other		 NOT_YET_RECRUITING 60 University of Michigan
OTHER		 2026-08-31
Transforming Maternal Mental Health Care
NCT07766174
Lōvu platform; Standard Care Arm
Runs in: United States · 1 site 		NA
other		 RECRUITING 50 University of Utah
OTHER		 2026-08-31
Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease
NCT07794670
Obicetrapib 10 mg; Matching placebo tablets 		PHASE2
other		 NOT_YET_RECRUITING 400 NewAmsterdam Pharma
INDUSTRY		 2026-08-31
LpD3.5 Intervention Study in Older Adults- LISA-I Trial
NCT07794956
LpD3.5; Placebo
Runs in: United States · 1 site 		EARLY_PHASE1
other		 RECRUITING 15 University of South Florida
OTHER		 2026-08-31
Repurposing a Combination Antiretroviral Drug Therapy to Target Retrotransposons and Treat Early Alzheimer's Disease
NCT07795307
Emtricitabine and tenofovir disoproxil fumarate combination; Placebo
Runs in: United States · 1 site 		PHASE1
other		 NOT_YET_RECRUITING 20 Brigham and Women's Hospital
OTHER		 2026-08-31
Researching Resiliency in Stressful Experiences (RISE) Program for Men Leaving Incarceration
NCT04785677
Resiliency in Stressful Experiences (RISE) Program
Runs in: United States · 1 site 		NA
other		 COMPLETED 403 Florida State University
OTHER		 2026-08-28
Alzheimer's Disease Neuroimaging Initiative 4
NCT05617014
Neuraceq; Amyvid; Tauvid; MK-6240; NAV4694; PI-2620
Runs in: Canada; United States · 65 sites 		NA
other		 ENROLLING_BY_INVITATION 1,500 University of Southern California
OTHER		 2026-08-28
A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
NCT06544616
JNJ-64042056; Placebo
Runs in: Australia; Belgium; France; Germany; Japan; Spain; Sweden... · 90 sites 		PHASE2
other		 ACTIVE_NOT_RECRUITING 55 Janssen Pharmaceutica N.V., Belgium
INDUSTRY		 2026-08-28
Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypical Parkinsonisms and Neurocognitive Disorders Due to Lewy Body Disease
NCT06846658
Runs in: Italy · 3 sites 		NA
other		 ACTIVE_NOT_RECRUITING 180 Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
OTHER		 2026-08-28
Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches
NCT06856850
Runs in: Italy · 4 sites 		NA
other		 ACTIVE_NOT_RECRUITING 230 Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
OTHER		 2026-08-28
PrP-targeting siRNA Safety & Mechanism Study
NCT07444580
PrP-siRNA
Runs in: United States · 5 sites 		PHASE1
other		 RECRUITING 30 Broad Institute of MIT and Harvard
OTHER		 2026-08-28
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
NCT07633470
Zunveyl®
Runs in: United States · 14 sites 		PHASE4
other		 RECRUITING 150 Alpha Cognition, Inc
INDUSTRY		 2026-08-28
Momentary Coping Prompts and Hair Steroids in College Students
NCT07782398
Momentary coping prompt; Active control message
Runs in: United States · 1 site 		NA
other		 NOT_YET_RECRUITING 80 University of Florida
OTHER		 2026-08-28
AIM 3 Focused Adaptation of a Mobile Caregiver Intervention for Dementia Caregivers
NCT07792889
Brain CareNotes Latino; Dementia Care app 		NA
other		 NOT_YET_RECRUITING 60 Indiana University
OTHER		 2026-08-28
CADASIL Disease Discovery
NCT02821780
Runs in: United States · 2 sites 		NA
other		 COMPLETED 20 National Heart, Lung, and Blood Institute (NHLBI)
NIH		 2026-08-27

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →